183 related articles for article (PubMed ID: 36804669)
1. Ligand-induced conformational changes enable intersubunit communications in D-dopachrome tautomerase.
Parkins A; Chen E; Rangel VM; Singh M; Xue L; Lisi GP; Pantouris G
Biophys J; 2023 Apr; 122(7):1268-1276. PubMed ID: 36804669
[TBL] [Abstract][Full Text] [Related]
2. 2,5-Pyridinedicarboxylic acid is a bioactive and highly selective inhibitor of D-dopachrome tautomerase.
Parkins A; Das P; Prahaladan V; Rangel VM; Xue L; Sankaran B; Bhandari V; Pantouris G
Structure; 2023 Mar; 31(3):355-367.e4. PubMed ID: 36805127
[TBL] [Abstract][Full Text] [Related]
3. Modeling of both shared and distinct interactions between MIF and its homologue D-DT with their common receptor CD74.
Meza-Romero R; Benedek G; Jordan K; Leng L; Pantouris G; Lolis E; Bucala R; Vandenbark AA
Cytokine; 2016 Dec; 88():62-70. PubMed ID: 27573366
[TBL] [Abstract][Full Text] [Related]
4. A selective small-molecule inhibitor of macrophage migration inhibitory factor-2 (MIF-2), a MIF cytokine superfamily member, inhibits MIF-2 biological activity.
Tilstam PV; Pantouris G; Corman M; Andreoli M; Mahboubi K; Davis G; Du X; Leng L; Lolis E; Bucala R
J Biol Chem; 2019 Dec; 294(49):18522-18531. PubMed ID: 31578280
[TBL] [Abstract][Full Text] [Related]
5. Extracellular MIF, but not its homologue D-DT, promotes fibroblast motility independently of its receptor complex CD74/CD44.
Szczęśniak P; Henke T; Fröhlich S; Plessmann U; Urlaub H; Leng L; Bucala R; Grosse R; Meinhardt A; Klug J
J Cell Sci; 2021 Feb; 134(3):. PubMed ID: 33328325
[TBL] [Abstract][Full Text] [Related]
6. D-dopachrome tautomerase in adipose tissue inflammation and wound repair.
Kim BS; Tilstam PV; Hwang SS; Simons D; Schulte W; Leng L; Sauler M; Ganse B; Averdunk L; Kopp R; Stoppe C; Bernhagen J; Pallua N; Bucala R
J Cell Mol Med; 2017 Jan; 21(1):35-45. PubMed ID: 27605340
[TBL] [Abstract][Full Text] [Related]
7. MIF, CD74 and other partners in kidney disease: tales of a promiscuous couple.
Sanchez-Niño MD; Sanz AB; Ruiz-Andres O; Poveda J; Izquierdo MC; Selgas R; Egido J; Ortiz A
Cytokine Growth Factor Rev; 2013 Feb; 24(1):23-40. PubMed ID: 22959722
[TBL] [Abstract][Full Text] [Related]
8. Mapping N- to C-terminal allosteric coupling through disruption of a putative CD74 activation site in D-dopachrome tautomerase.
Chen E; Widjaja V; Kyro G; Allen B; Das P; Prahaladan VM; Bhandari V; Lolis EJ; Batista VS; Lisi GP
J Biol Chem; 2023 Jun; 299(6):104729. PubMed ID: 37080391
[TBL] [Abstract][Full Text] [Related]
9. The D-dopachrome tautomerase (DDT) gene product is a cytokine and functional homolog of macrophage migration inhibitory factor (MIF).
Merk M; Zierow S; Leng L; Das R; Du X; Schulte W; Fan J; Lue H; Chen Y; Xiong H; Chagnon F; Bernhagen J; Lolis E; Mor G; Lesur O; Bucala R
Proc Natl Acad Sci U S A; 2011 Aug; 108(34):E577-85. PubMed ID: 21817065
[TBL] [Abstract][Full Text] [Related]
10. Increased CD74 binding and EAE treatment efficacy of a modified DRα1 molecular construct.
Meza-Romero R; Benedek G; Gerstner G; Kent G; Nguyen H; Offner H; Vandenbark AA
Metab Brain Dis; 2019 Feb; 34(1):153-164. PubMed ID: 30353480
[TBL] [Abstract][Full Text] [Related]
11. D-dopachrome tautomerase activates COX2/PGE
Ji H; Zhang Y; Chen C; Li H; He B; Yang T; Sun C; Hao H; Zhang X; Wang Y; Zhou Y; Zhu Z; Hu Y; Li A; Guo A; Wang Y
J Neuroinflammation; 2021 Jun; 18(1):130. PubMed ID: 34116703
[TBL] [Abstract][Full Text] [Related]
12. MIF and D-DT are potential disease severity modifiers in male MS subjects.
Benedek G; Meza-Romero R; Jordan K; Zhang Y; Nguyen H; Kent G; Li J; Siu E; Frazer J; Piecychna M; Du X; Sreih A; Leng L; Wiedrick J; Caillier SJ; Offner H; Oksenberg JR; Yadav V; Bourdette D; Bucala R; Vandenbark AA
Proc Natl Acad Sci U S A; 2017 Oct; 114(40):E8421-E8429. PubMed ID: 28923927
[TBL] [Abstract][Full Text] [Related]
13. The N-terminus of MIF regulates the dynamic profile of residues involved in CD74 activation.
Parkins A; Skeens E; McCallum CM; Lisi GP; Pantouris G
Biophys J; 2021 Sep; 120(18):3893-3900. PubMed ID: 34437846
[TBL] [Abstract][Full Text] [Related]
14. A structurally preserved allosteric site in the MIF superfamily affects enzymatic activity and CD74 activation in D-dopachrome tautomerase.
Chen E; Reiss K; Shah D; Manjula R; Allen B; Murphy EL; Murphy JW; Batista VS; Bhandari V; Lolis EJ; Lisi GP
J Biol Chem; 2021 Sep; 297(3):101061. PubMed ID: 34384784
[TBL] [Abstract][Full Text] [Related]
15. CD74 in Kidney Disease.
Valiño-Rivas L; Baeza-Bermejillo C; Gonzalez-Lafuente L; Sanz AB; Ortiz A; Sanchez-Niño MD
Front Immunol; 2015; 6():483. PubMed ID: 26441987
[TBL] [Abstract][Full Text] [Related]
16. D-dopachrome tautomerase (D-DT or MIF-2): doubling the MIF cytokine family.
Merk M; Mitchell RA; Endres S; Bucala R
Cytokine; 2012 Jul; 59(1):10-7. PubMed ID: 22507380
[TBL] [Abstract][Full Text] [Related]
17. The biological function and significance of CD74 in immune diseases.
Su H; Na N; Zhang X; Zhao Y
Inflamm Res; 2017 Mar; 66(3):209-216. PubMed ID: 27752708
[TBL] [Abstract][Full Text] [Related]
18. Cooperative regulation of non-small cell lung carcinoma angiogenic potential by macrophage migration inhibitory factor and its homolog, D-dopachrome tautomerase.
Coleman AM; Rendon BE; Zhao M; Qian MW; Bucala R; Xin D; Mitchell RA
J Immunol; 2008 Aug; 181(4):2330-7. PubMed ID: 18684922
[TBL] [Abstract][Full Text] [Related]
19. Negative regulation of AMP-activated protein kinase (AMPK) activity by macrophage migration inhibitory factor (MIF) family members in non-small cell lung carcinomas.
Brock SE; Rendon BE; Yaddanapudi K; Mitchell RA
J Biol Chem; 2012 Nov; 287(45):37917-25. PubMed ID: 22988252
[TBL] [Abstract][Full Text] [Related]
20. An Analysis of MIF Structural Features that Control Functional Activation of CD74.
Pantouris G; Syed MA; Fan C; Rajasekaran D; Cho TY; Rosenberg EM; Bucala R; Bhandari V; Lolis EJ
Chem Biol; 2015 Sep; 22(9):1197-205. PubMed ID: 26364929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
